monoclonal antibodies ( mabs ) directed against gram-negative bacterial lipopolysaccharide ( endotoxin , lps ) are currently being evaluated as an adjunctive form of therapy for lethal gram-negative bacterial sepsis and shock .
C0014264
endotoxin
C0023810
lps